{"id": "article-24177_0", "title": "Leiomyoma -- Continuing Education Activity", "content": "Leiomyomas, also known as fibroids, are a group of benign smooth muscle tumors commonly present in premenopausal women. These tumors are of monoclonal origin which arises from the smooth muscle of the uterus. This activity describes the evaluation and treatment of leiomyomas and explains the role of the interprofessional team in managing patients with this condition.", "contents": "Leiomyoma -- Continuing Education Activity. Leiomyomas, also known as fibroids, are a group of benign smooth muscle tumors commonly present in premenopausal women. These tumors are of monoclonal origin which arises from the smooth muscle of the uterus. This activity describes the evaluation and treatment of leiomyomas and explains the role of the interprofessional team in managing patients with this condition."}
{"id": "article-24177_1", "title": "Leiomyoma -- Continuing Education Activity", "content": "Objectives: Review the risk factors for developing leiomyoma. Describe the hormone responsiveness of tumors in the pathophysiology of leiomyomas. Explain the FIGO classification in the evaluation of leiomyomas. Outline the imporatance of improving care coordination among the interprofessional team to enhance delivery of care for patients affected by leiomyoma. Access free multiple choice questions on this topic.", "contents": "Leiomyoma -- Continuing Education Activity. Objectives: Review the risk factors for developing leiomyoma. Describe the hormone responsiveness of tumors in the pathophysiology of leiomyomas. Explain the FIGO classification in the evaluation of leiomyomas. Outline the imporatance of improving care coordination among the interprofessional team to enhance delivery of care for patients affected by leiomyoma. Access free multiple choice questions on this topic."}
{"id": "article-24177_2", "title": "Leiomyoma -- Introduction", "content": "Leiomyomas, also called fibroids, are the most common benign gynecological tumor in premenopausal women [1] [2] . The economic impact of fibroids is profound, affecting an estimated 11 million women [3] and costing approximately 34 billion dollars in the United States annually [4] . This article presents the general approach to diagnosis, pathophysiology, histology, and treatment\u00a0of leiomyomas.", "contents": "Leiomyoma -- Introduction. Leiomyomas, also called fibroids, are the most common benign gynecological tumor in premenopausal women [1] [2] . The economic impact of fibroids is profound, affecting an estimated 11 million women [3] and costing approximately 34 billion dollars in the United States annually [4] . This article presents the general approach to diagnosis, pathophysiology, histology, and treatment\u00a0of leiomyomas."}
{"id": "article-24177_3", "title": "Leiomyoma -- Etiology", "content": "Leiomyomas are comprised of monoclonal cells arising from the myometrium [5] . Continued\u00a0research\u00a0to determine the\u00a0etiology of leiomyomas is ongoing. Several studies have\u00a0identified\u00a0specific gene mutations associated with fibroids [2] .\u00a0Some mutations have been linked to defects in cell transformation\u00a0involving the RNA polymerase II transcriptional mediator subunit, MED12 [5] .", "contents": "Leiomyoma -- Etiology. Leiomyomas are comprised of monoclonal cells arising from the myometrium [5] . Continued\u00a0research\u00a0to determine the\u00a0etiology of leiomyomas is ongoing. Several studies have\u00a0identified\u00a0specific gene mutations associated with fibroids [2] .\u00a0Some mutations have been linked to defects in cell transformation\u00a0involving the RNA polymerase II transcriptional mediator subunit, MED12 [5] ."}
{"id": "article-24177_4", "title": "Leiomyoma -- Epidemiology", "content": "Leiomyomas are diagnosed in\u00a0close to 70% of white women and more than 80% of black women\u00a0by age 50, but the incidence of clinical symptoms\u00a0in\u00a0blacks is\u00a0double that found in\u00a0whites [2] .\u00a0 In addition to African descent, several factors are commonly associated with a higher risk of developing fibroids: early menarche, use of oral contraception before the age of 16 and an increase in body mass index. Conversely, the use of progestin-only contraceptives as well as multiparity decrease this risk [2] .", "contents": "Leiomyoma -- Epidemiology. Leiomyomas are diagnosed in\u00a0close to 70% of white women and more than 80% of black women\u00a0by age 50, but the incidence of clinical symptoms\u00a0in\u00a0blacks is\u00a0double that found in\u00a0whites [2] .\u00a0 In addition to African descent, several factors are commonly associated with a higher risk of developing fibroids: early menarche, use of oral contraception before the age of 16 and an increase in body mass index. Conversely, the use of progestin-only contraceptives as well as multiparity decrease this risk [2] ."}
{"id": "article-24177_5", "title": "Leiomyoma -- Pathophysiology", "content": "Clinically, it is well established that leiomyomas are highly sensitive to the effects of steroid hormones. Leiomyomas have an increased expression of both estrogen and progesterone receptors when compared to normal myometrium [6] . Studies indicate that ovarian steroids, estradiol, and progesterone, promote the growth of leiomyomas; and that the size of fibroids often decline after menopause when levels of those hormones fall [7] .", "contents": "Leiomyoma -- Pathophysiology. Clinically, it is well established that leiomyomas are highly sensitive to the effects of steroid hormones. Leiomyomas have an increased expression of both estrogen and progesterone receptors when compared to normal myometrium [6] . Studies indicate that ovarian steroids, estradiol, and progesterone, promote the growth of leiomyomas; and that the size of fibroids often decline after menopause when levels of those hormones fall [7] ."}
{"id": "article-24177_6", "title": "Leiomyoma -- Histopathology", "content": "Leiomyomas are benign tumors\u00a0of monoclonal origin which arise from the smooth muscle of the uterus [2] [8] . Leiomyomas are primarily composed of extracellular matrix and cells with a low mitotic index [7] [8] . They are encapsulated with a pseudocapsule composed of areolar tissue [8] .", "contents": "Leiomyoma -- Histopathology. Leiomyomas are benign tumors\u00a0of monoclonal origin which arise from the smooth muscle of the uterus [2] [8] . Leiomyomas are primarily composed of extracellular matrix and cells with a low mitotic index [7] [8] . They are encapsulated with a pseudocapsule composed of areolar tissue [8] ."}
{"id": "article-24177_7", "title": "Leiomyoma -- History and Physical", "content": "The clinical presentation of fibroids is variable, ranging from asymptomatic patients to those with recurrent, progressive symptoms that adversely affect a woman\u2019s daily activities. The most common presenting symptoms are pain, pressure, and abnormal vaginal bleeding [7] . Important determinants of symptoms are the location, size, and the number of leiomyomas [1] . Physical examination usually confirms an enlarged, irregularly-shaped uterus [2] .", "contents": "Leiomyoma -- History and Physical. The clinical presentation of fibroids is variable, ranging from asymptomatic patients to those with recurrent, progressive symptoms that adversely affect a woman\u2019s daily activities. The most common presenting symptoms are pain, pressure, and abnormal vaginal bleeding [7] . Important determinants of symptoms are the location, size, and the number of leiomyomas [1] . Physical examination usually confirms an enlarged, irregularly-shaped uterus [2] ."}
{"id": "article-24177_8", "title": "Leiomyoma -- Evaluation", "content": "Diagnosis of uterine leiomyomas is generally made by comprehensive physical examination and clinical history. On physical exam, the most common finding is an enlarged uterus that is often irregular in shape. Confirmation of\u00a0clinical diagnosis is most easily\u00a0accomplished with ultrasonography.\u00a0A pelvic sonogram\u00a0is a cost-effective method that allows for rapid diagnosis [2] .", "contents": "Leiomyoma -- Evaluation. Diagnosis of uterine leiomyomas is generally made by comprehensive physical examination and clinical history. On physical exam, the most common finding is an enlarged uterus that is often irregular in shape. Confirmation of\u00a0clinical diagnosis is most easily\u00a0accomplished with ultrasonography.\u00a0A pelvic sonogram\u00a0is a cost-effective method that allows for rapid diagnosis [2] ."}
{"id": "article-24177_9", "title": "Leiomyoma -- Evaluation", "content": "Further imaging, such as magnetic resonance imaging (MRI), can be useful for determining the extent of vascularization or degeneration of the leiomyomas. MRI can also better define the relationship of the leiomyomas to the serosal and mucosal surfaces. The proximity to these surfaces often dictates the type of intervention recommended [2] .", "contents": "Leiomyoma -- Evaluation. Further imaging, such as magnetic resonance imaging (MRI), can be useful for determining the extent of vascularization or degeneration of the leiomyomas. MRI can also better define the relationship of the leiomyomas to the serosal and mucosal surfaces. The proximity to these surfaces often dictates the type of intervention recommended [2] ."}
{"id": "article-24177_10", "title": "Leiomyoma -- Evaluation", "content": "The International Federation of Gynecology and Obstetrics (FIGO) has developed a classification system that allows for the determination of the extent of invasion into the endometrial cavity. The FIGO scale ranges from 0 to 8, with the lower number indicating closer proximity to the endometrium [2] [9] .", "contents": "Leiomyoma -- Evaluation. The International Federation of Gynecology and Obstetrics (FIGO) has developed a classification system that allows for the determination of the extent of invasion into the endometrial cavity. The FIGO scale ranges from 0 to 8, with the lower number indicating closer proximity to the endometrium [2] [9] ."}
{"id": "article-24177_11", "title": "Leiomyoma -- Evaluation", "content": "If bleeding is the predominant symptom and there is a concern for anemia or other sequelae of recurrent blood loss, a complete blood count (CBC) is indicated. Further evaluation of blood work should include a thyroid-stimulating hormone level to rule out thyroid disease as the cause of abnormal bleeding if the index of suspicion is low for leiomyomata\u00a0as the etiology [2] .", "contents": "Leiomyoma -- Evaluation. If bleeding is the predominant symptom and there is a concern for anemia or other sequelae of recurrent blood loss, a complete blood count (CBC) is indicated. Further evaluation of blood work should include a thyroid-stimulating hormone level to rule out thyroid disease as the cause of abnormal bleeding if the index of suspicion is low for leiomyomata\u00a0as the etiology [2] ."}
{"id": "article-24177_12", "title": "Leiomyoma -- Evaluation", "content": "At this time, there is no recommendation for surveillance imaging. While the growth of the leiomyoma can be surveyed, there is no current basis for a set time interval or current guidelines on how the growth should be monitored. Interval reassessment is usually based on a change in clinical symptoms [2] .", "contents": "Leiomyoma -- Evaluation. At this time, there is no recommendation for surveillance imaging. While the growth of the leiomyoma can be surveyed, there is no current basis for a set time interval or current guidelines on how the growth should be monitored. Interval reassessment is usually based on a change in clinical symptoms [2] ."}
{"id": "article-24177_13", "title": "Leiomyoma -- Treatment / Management", "content": "The economic impact on the United States by the cost of care for symptomatic leiomyomas is excessive [1] . Effective treatment is necessary to not only reduce the detrimental effects they pose on a women\u2019s daily function, but also to mitigate the economic burden on healthcare [2] .", "contents": "Leiomyoma -- Treatment / Management. The economic impact on the United States by the cost of care for symptomatic leiomyomas is excessive [1] . Effective treatment is necessary to not only reduce the detrimental effects they pose on a women\u2019s daily function, but also to mitigate the economic burden on healthcare [2] ."}
{"id": "article-24177_14", "title": "Leiomyoma -- Treatment / Management", "content": "The patient\u2019s age and reproductive goals direct the modality and goals of treatment. Treatment options include both medical and surgical intervention [1] . Treatment goals should fulfill three objectives: Relieve\u00a0bothersome signs and symptoms Reduce\u00a0the leiomyoma size Maintain or improve a woman\u2019s fertility if desired [1] .", "contents": "Leiomyoma -- Treatment / Management. The patient\u2019s age and reproductive goals direct the modality and goals of treatment. Treatment options include both medical and surgical intervention [1] . Treatment goals should fulfill three objectives: Relieve\u00a0bothersome signs and symptoms Reduce\u00a0the leiomyoma size Maintain or improve a woman\u2019s fertility if desired [1] ."}
{"id": "article-24177_15", "title": "Leiomyoma -- Treatment / Management", "content": "Medical management is often the initial intervention for symptomatic fibroids and includes hormonal therapy, nonsteroidal anti-inflammatory drugs (NSAIDs) and/or modulation of the hypothalamic-pituitary axis. The major\u00a0drawback of medical management is the limited duration of use. Many of the medical management options are only able to be used for a short duration, and after the cessation of treatment,\u00a0symptoms reoccur,\u00a0and the fibroids often continue to grow [1] .", "contents": "Leiomyoma -- Treatment / Management. Medical management is often the initial intervention for symptomatic fibroids and includes hormonal therapy, nonsteroidal anti-inflammatory drugs (NSAIDs) and/or modulation of the hypothalamic-pituitary axis. The major\u00a0drawback of medical management is the limited duration of use. Many of the medical management options are only able to be used for a short duration, and after the cessation of treatment,\u00a0symptoms reoccur,\u00a0and the fibroids often continue to grow [1] ."}
{"id": "article-24177_16", "title": "Leiomyoma -- Treatment / Management", "content": "Hormonal options for treatment include combination oral contraceptives, single agent progesterone suppression or GnRH agonists. Systemic hormonal therapy is primarily used to control menorrhagia caused by fibroids,\u00a0rarely\u00a0impacts the size of fibroids and does not improve fertility.\u00a0 Additionally, increased complications are associated with long-term treatment\u00a0using exogenous hormones; therefore, they are generally only used for short durations [1] . Gonadotropin-releasing hormone (GnRH) agonists\u00a0inhibit\u00a0production of endogenous progesterone and estrogen.\u00a0 The overall\u00a0effects are similar to those of menopause, thus resulting in amenorrhea and subsequent decrease in uterine volume [1] [2] .\u00a0 However, these effects are limited to the duration of use.", "contents": "Leiomyoma -- Treatment / Management. Hormonal options for treatment include combination oral contraceptives, single agent progesterone suppression or GnRH agonists. Systemic hormonal therapy is primarily used to control menorrhagia caused by fibroids,\u00a0rarely\u00a0impacts the size of fibroids and does not improve fertility.\u00a0 Additionally, increased complications are associated with long-term treatment\u00a0using exogenous hormones; therefore, they are generally only used for short durations [1] . Gonadotropin-releasing hormone (GnRH) agonists\u00a0inhibit\u00a0production of endogenous progesterone and estrogen.\u00a0 The overall\u00a0effects are similar to those of menopause, thus resulting in amenorrhea and subsequent decrease in uterine volume [1] [2] .\u00a0 However, these effects are limited to the duration of use."}
{"id": "article-24177_17", "title": "Leiomyoma -- Treatment / Management", "content": "Intrauterine devices that release levonorgestrel act locally to achieve results similar to systemic progesterone suppression, resulting in decreased menstrual bleeding and improved quality of life [2] . While they provide symptomatic relief, they do not have any long-term effect on decreasing the overall size of the uterine fibroids; thus providing little help with bulk symptoms [2] .", "contents": "Leiomyoma -- Treatment / Management. Intrauterine devices that release levonorgestrel act locally to achieve results similar to systemic progesterone suppression, resulting in decreased menstrual bleeding and improved quality of life [2] . While they provide symptomatic relief, they do not have any long-term effect on decreasing the overall size of the uterine fibroids; thus providing little help with bulk symptoms [2] ."}
{"id": "article-24177_18", "title": "Leiomyoma -- Treatment / Management", "content": "Non-hormonal options involve NSAIDs and tranexamic acid. Tranexamic acid is a derivative of the amino acid, lysine.\u00a0 This medication is\u00a0a reversible inhibitor of lysine receptor sites\u00a0on plasminogen\u00a0that, when bound, prevent\u00a0fibrin degradation\u00a0and\u00a0functionally stabilize clot\u00a0formation [1] . There are few side effects associated with tranexamic acid. The most common\u00a0is gastrointestinal upset, while the most feared is venous thromboembolism [1] [2] .\u00a0Clinical\u00a0studies have found no significant evidence for the\u00a0theoretical increased risk of venous thromboembolism\u00a0from use of tranexamic acid [1] . However, due to potential increased thrombotic risk with hormonal therapy, tranexamic acid is usually prescribed as a single agent therapy [2] .", "contents": "Leiomyoma -- Treatment / Management. Non-hormonal options involve NSAIDs and tranexamic acid. Tranexamic acid is a derivative of the amino acid, lysine.\u00a0 This medication is\u00a0a reversible inhibitor of lysine receptor sites\u00a0on plasminogen\u00a0that, when bound, prevent\u00a0fibrin degradation\u00a0and\u00a0functionally stabilize clot\u00a0formation [1] . There are few side effects associated with tranexamic acid. The most common\u00a0is gastrointestinal upset, while the most feared is venous thromboembolism [1] [2] .\u00a0Clinical\u00a0studies have found no significant evidence for the\u00a0theoretical increased risk of venous thromboembolism\u00a0from use of tranexamic acid [1] . However, due to potential increased thrombotic risk with hormonal therapy, tranexamic acid is usually prescribed as a single agent therapy [2] ."}
{"id": "article-24177_19", "title": "Leiomyoma -- Treatment / Management", "content": "NSAIDs have been useful for reducing menstrual blood loss [1] . NSAIDs decrease the endometrial prostaglandins, which subsequently inhibit aberrant vascularization and neovascularization [1] [2] . While NSAIDs\u00a0are effective for decreasing menstrual flow, they are inferior to tranexamic acid and levonorgestrel-releasing IUDs [2] [10] .", "contents": "Leiomyoma -- Treatment / Management. NSAIDs have been useful for reducing menstrual blood loss [1] . NSAIDs decrease the endometrial prostaglandins, which subsequently inhibit aberrant vascularization and neovascularization [1] [2] . While NSAIDs\u00a0are effective for decreasing menstrual flow, they are inferior to tranexamic acid and levonorgestrel-releasing IUDs [2] [10] ."}
{"id": "article-24177_20", "title": "Leiomyoma -- Treatment / Management", "content": "Surgical intervention remains the\u00a0most successful\u00a0treatment for leiomyomas. Endometrial ablation is hysteroscopic destruction of the full-thickness endometrium, but this treatment precludes future endometrial assessment and requires permanent contraception.\u00a0 Uterine artery embolization reduces blood flow to individual fibroids to reduce growth and mitigate symptoms.\u00a0 Successful myomectomy (surgical removal of fibroids only) enables future fertility while reducing size and symptoms from fibroids; however, many women will require additional\u00a0subsequent procedures for recurrent symptomatic fibroids.\u00a0 Hysterectomy is the only treatment that provides definitive therapy [2] . There are various methods of performing a hysterectomy, the choice\u00a0of which is highly dependent on the patients\u2019 history, physical findings and the individual surgeon's\u00a0training and experience [2] .", "contents": "Leiomyoma -- Treatment / Management. Surgical intervention remains the\u00a0most successful\u00a0treatment for leiomyomas. Endometrial ablation is hysteroscopic destruction of the full-thickness endometrium, but this treatment precludes future endometrial assessment and requires permanent contraception.\u00a0 Uterine artery embolization reduces blood flow to individual fibroids to reduce growth and mitigate symptoms.\u00a0 Successful myomectomy (surgical removal of fibroids only) enables future fertility while reducing size and symptoms from fibroids; however, many women will require additional\u00a0subsequent procedures for recurrent symptomatic fibroids.\u00a0 Hysterectomy is the only treatment that provides definitive therapy [2] . There are various methods of performing a hysterectomy, the choice\u00a0of which is highly dependent on the patients\u2019 history, physical findings and the individual surgeon's\u00a0training and experience [2] ."}
{"id": "article-24177_21", "title": "Leiomyoma -- Differential Diagnosis", "content": "The differential diagnosis for uterine leiomyomas includes both benign and malignant diseases that cause uterine enlargement, bleeding or pelvic pain. The most common diagnoses to consider are adenomyosis, endometriosis, pregnancy, leiomyosarcoma, endometrial carcinoma and uterine carcinosarcoma [11] . While these cancers are rare causes of symptoms consistent with leiomyomas, the clinician must maintain a high index of suspicion during evaluation.", "contents": "Leiomyoma -- Differential Diagnosis. The differential diagnosis for uterine leiomyomas includes both benign and malignant diseases that cause uterine enlargement, bleeding or pelvic pain. The most common diagnoses to consider are adenomyosis, endometriosis, pregnancy, leiomyosarcoma, endometrial carcinoma and uterine carcinosarcoma [11] . While these cancers are rare causes of symptoms consistent with leiomyomas, the clinician must maintain a high index of suspicion during evaluation."}
{"id": "article-24177_22", "title": "Leiomyoma -- Prognosis", "content": "The prognosis of uterine fibroids varies extensively\u00a0for individual patients. Many patients have an excellent prognosis and remain asymptomatic for many years or indefinitely. Whereas, others will fail medical management and depending on their desire for future fertility, may\u00a0experience recurrent fibroids requiring multiple surgeries.", "contents": "Leiomyoma -- Prognosis. The prognosis of uterine fibroids varies extensively\u00a0for individual patients. Many patients have an excellent prognosis and remain asymptomatic for many years or indefinitely. Whereas, others will fail medical management and depending on their desire for future fertility, may\u00a0experience recurrent fibroids requiring multiple surgeries."}
{"id": "article-24177_23", "title": "Leiomyoma -- Complications", "content": "Chronic pelvic pain Heavy menstrual bleeding, which can lead to anemia Poor pregnancy outcomes Infertility Constipation Urinary tract infections or urinary incontinence Torsion\u00a0of a pedunculated fibroid Degeneration\u00a0with or without infection", "contents": "Leiomyoma -- Complications. Chronic pelvic pain Heavy menstrual bleeding, which can lead to anemia Poor pregnancy outcomes Infertility Constipation Urinary tract infections or urinary incontinence Torsion\u00a0of a pedunculated fibroid Degeneration\u00a0with or without infection"}
{"id": "article-24177_24", "title": "Leiomyoma -- Deterrence and Patient Education", "content": "Leiomyomas are benign and rarely become cancer Extremely common among women Genetics may play a role in your chance of developing them", "contents": "Leiomyoma -- Deterrence and Patient Education. Leiomyomas are benign and rarely become cancer Extremely common among women Genetics may play a role in your chance of developing them"}
{"id": "article-24177_25", "title": "Leiomyoma -- Enhancing Healthcare Team Outcomes", "content": "Considering the high prevalence and incidence of uterine leiomyomas, the need for full integration of care among health care professionals is essential. To expand our knowledge of leiomyomas, we need further research to identify predisposing genetic factors for potential use to better target\u00a0preventive care. Current randomized trials have shown progress in the treatment of symptoms to improve quality of life. One of the most recent phase three trials found the use of ulipristal acetate, an oral progesterone receptor modulator significantly improves bleeding among women with symptomatic leiomyomas [12] . While this is a step in the right direction, the need for further understanding of the\u00a0pathophysiology of leiomyomas is essential for\u00a0optimal care of this large population of patients.", "contents": "Leiomyoma -- Enhancing Healthcare Team Outcomes. Considering the high prevalence and incidence of uterine leiomyomas, the need for full integration of care among health care professionals is essential. To expand our knowledge of leiomyomas, we need further research to identify predisposing genetic factors for potential use to better target\u00a0preventive care. Current randomized trials have shown progress in the treatment of symptoms to improve quality of life. One of the most recent phase three trials found the use of ulipristal acetate, an oral progesterone receptor modulator significantly improves bleeding among women with symptomatic leiomyomas [12] . While this is a step in the right direction, the need for further understanding of the\u00a0pathophysiology of leiomyomas is essential for\u00a0optimal care of this large population of patients."}
{"id": "article-24177_26", "title": "Leiomyoma -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Leiomyoma -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}